Nab-paclitaxel plus capecitabine as first-line treatment for patients with recurrence or metastatic biliary tract cancer

被引：0
|
作者：
Zhou, J. [1 ]
Zong, Y. [1 ]
Yuan, J. [1 ]
Peng, Z. [1 ]
Lu, M. [1 ]
Wang, X. [1 ]
Shen, L. [1 ]
机构：
[1] Beijing Canc Hosp, Dept Gastrointestinal Oncol, Beijing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.10.458
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
194P
引用
收藏
页码：S1315 / S1315
页数：1
相关论文
共 50 条
  • [1] Nab-paclitaxel plus capecitabine as a first-line regimen for advanced biliary tract cancers: Feasible or not feasible?
    Chen, Jian-Qiang
    Lan, Xiang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2025, 31 (10)
  • [2] Nab-paclitaxel plus platinum versus paclitaxel plus platinum as first-line therapy in patients with metastatic or recurrent cervical cancer
    Liu, Yuan
    Fang, Shan-shan
    Zhao, Run-sheng
    Liu, Bo
    Jin, Yi-qiang
    Li, Quan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (06)
  • [3] Safety and efficacy of first-line gemcitabine plus nab-paclitaxel for elderly metastatic pancreatic cancer patients
    Pecora, I.
    Vivaldi, C.
    Rovesti, G.
    Catanese, S.
    Salani, F.
    Gardini, A. Casadei
    Massa, V.
    Bernardini, L.
    Riggi, M.
    Andrikou, K.
    Rapposelli, I.
    Formica, V.
    Cesario, S.
    Caccese, M.
    Lencioni, M.
    Vasile, E.
    Falcone, A.
    Fornaro, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S151 - S151
  • [4] Efficacy and toxicity comparison of nab-paclitaxel plus S-1 and nab-paclitaxel plus gemcitabine as first-line chemotherapy for metastatic pancreatic cancer
    Guo Xi
    Xu Yaolin
    Ji Yuan
    Fan Yue
    Wang Dansong
    Jin Dayong
    Zhuang Rongyuan
    Wu Lili
    Lou Wenhui
    Zhou Yuhong
    Department of Medical Oncology
    Department of General Surgery
    Department of Pathology
    Department of Traditional Chinese Medicine
    Department of Radiotherapy
    胰腺病学杂志（英文）, 2020, 03 (01) : 35 - 41
  • [5] Carboplatin, nab-paclitaxel and bevacizumab as first-line treatment for metastatic breast cancer.
    Lo, S. S.
    Guo, R.
    Czaplicki, K. L.
    Robinson, P. A.
    Gaynor, E.
    Barhamand, F. B.
    Schulz, W. C.
    Kash, J. J.
    Horvath, L. E.
    Bayer, R. A.
    Petrowsky, C.
    De la Torre, R.
    Park, J. H.
    Albain, K. S.
    CANCER RESEARCH, 2012, 72
  • [6] FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer
    Ay, Seval
    Atci, Muhammed Mustafa
    Arikan, Rukiye
    Dulgar, Ozgecan
    Ozyukseler, Deniz Tataroglu
    Paksoy, Nail
    Dogan, Izzet
    Oztosun, Bugra
    Tastekin, Didem
    Oven, Basak Bala
    Gumus, Mahmut
    JOURNAL OF CHEMOTHERAPY, 2022, 34 (07) : 465 - 471
  • [7] First-line gemcitabine plus nab-paclitaxel for elderly patients with metastatic pancreatic cancer: Crossing the frontier of age?
    Vivaldi, Caterina
    Salani, Francesca
    Rovesti, Giulia
    Pecora, Irene
    Catanese, Silvia
    Casadei-Gardini, Andrea
    Massa, Valentina
    Bernardini, Laura
    Riggi, Laura
    Andrikou, Kalliopi
    Rapposelli, Giovanni I.
    Formica, Vincenzo
    Lencioni, Monica
    Falcone, Alfredo
    Vasile, Enrico
    Fornaro, Lorenzo
    EUROPEAN JOURNAL OF CANCER, 2020, 137 : 108 - 116
  • [8] Gemcitabine, Cisplatin, and Nab-Paclitaxel as a First-Line Therapy for Advanced Biliary Tract Cancers
    Gedela, Sandeep
    Munot, Pritesh
    Vaidyanathan, Arvind
    Joarder, Ritam
    Chaugule, Deepali
    Parulekar, Manali
    Nashikkar, Chaitali
    Ghadi, Aayushi
    Vadodaria, Divya
    Goel, Mahesh
    Patkar, Shraddha
    Mandavkar, Sarika
    Ramaswamy, Anant
    Bhargava, Prabhat
    Srinivas, Sujay
    Ostwal, Vikas
    JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (01) : 263 - 269
  • [9] Gemcitabine, Cisplatin, and Nab-Paclitaxel as a First-Line Therapy for Advanced Biliary Tract Cancers
    Sandeep Gedela
    Pritesh Munot
    Arvind Vaidyanathan
    Ritam Joarder
    Deepali Chaugule
    Manali Parulekar
    Chaitali Nashikkar
    Aayushi Ghadi
    Divya Vadodaria
    Mahesh Goel
    Shraddha Patkar
    Sarika Mandavkar
    Anant Ramaswamy
    Prabhat Bhargava
    Sujay Srinivas
    Vikas Ostwal
    Journal of Gastrointestinal Cancer, 2024, 55 : 263 - 269
  • [10] Phase II trial of nab-paclitaxel (nanoparticle albumin-bound paclitaxel (ABX)) plus capecitabine (XEL) in first-line treatment of metastatic breast cancer (MBC)
    Somer, B. G.
    Schwartzberg, L. S.
    Arena, F.
    Epperson, A.
    Fu, D.
    Fortner, B. V.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345